us-abim MCQ (SBA): Atherosclerotic CVD-Residual Risk

Instant feedback + full explanation. One question, done properly.

HardCardiologyAtherosclerotic CVD-Residual Riskus-abim us-usmle-step-3

A 63-year-old with T2DM and ASCVD is on high-intensity statin and ezetimibe; LDL-C 78 mg/dL, triglycerides 220 mg/dL. Which additional lipid therapy reduces CV events?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

us-abim MCQ: Atherosclerotic CVD-Residual Risk — Answer & Explanation